Shandong Lukang Pharmaceutical Co Ltd (600789) — Free Cash Flow Generation Index
Shandong Lukang Pharmaceutical Co Ltd (600789) has a Free Cash Flow Generation Index of 0.69x as of June 2025. Free cash flow of CN¥196.54 Million represents 1% of operating cash flow (CN¥285.47 Million). Explore capital reinvestment ratio of Shandong Lukang Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shandong Lukang Pharmaceutical Co Ltd Free Cash Flow Generation Index (1998–2025)
Historical FCF Generation Index trend for Shandong Lukang Pharmaceutical Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see Shandong Lukang Pharmaceutical Co Ltd cash flow conversion.
Annual Free Cash Flow Generation for Shandong Lukang Pharmaceutical Co Ltd (1998–2025)
Year-by-year Free Cash Flow Generation Index for Shandong Lukang Pharmaceutical Co Ltd. Check 600789 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.51x | CN¥359.31 Million | CN¥698.17 Million | CN¥338.86 Million | ▲ +67.7% |
| 2024 | 0.31x | CN¥123.64 Million | CN¥402.82 Million | CN¥279.18 Million | ▼ -30.3% |
| 2023 | 0.44x | CN¥266.09 Million | CN¥604.01 Million | CN¥337.91 Million | ▲ +1122.3% |
| 2022 | 0.04x | CN¥16.02 Million | CN¥444.38 Million | CN¥428.36 Million | ▲ +101.6% |
| 2021 | -2.26x | CN¥-337.42 Million | CN¥149.33 Million | CN¥486.75 Million | ▼ -13.1% |
| 2020 | -2.00x | CN¥-468.57 Million | CN¥234.55 Million | CN¥703.12 Million | ▼ -54.9% |
| 2019 | -1.29x | CN¥-466.74 Million | CN¥361.87 Million | CN¥828.61 Million | ▲ +10.2% |
| 2018 | -1.44x | CN¥-504.15 Million | CN¥351.09 Million | CN¥855.24 Million | ▲ +21.7% |
| 2017 | -1.83x | CN¥-505.20 Million | CN¥275.51 Million | CN¥780.71 Million | ▼ -621.5% |
| 2016 | -0.25x | CN¥-75.28 Million | CN¥296.23 Million | CN¥371.51 Million | ▲ +76.9% |
| 2015 | -1.10x | CN¥-86.15 Million | CN¥78.39 Million | CN¥164.54 Million | ▼ -1172.2% |
| 2014 | -0.09x | CN¥-9.38 Million | CN¥108.56 Million | CN¥117.94 Million | ▼ -184.7% |
| 2013 | 0.10x | CN¥26.15 Million | CN¥256.50 Million | CN¥230.35 Million | ▲ +106.9% |
| 2012 | -1.47x | CN¥-169.20 Million | CN¥115.20 Million | CN¥284.40 Million | ▲ +40.7% |
| 2011 | -2.48x | CN¥-305.53 Million | CN¥123.28 Million | CN¥428.82 Million | ▼ -4306.7% |
| 2010 | 0.06x | CN¥18.20 Million | CN¥308.88 Million | CN¥290.69 Million | ▼ -91.0% |
| 2009 | 0.65x | CN¥129.93 Million | CN¥199.49 Million | CN¥69.57 Million | ▲ +2.7% |
| 2008 | 0.63x | CN¥132.81 Million | CN¥209.39 Million | CN¥76.58 Million | ▼ -23.6% |
| 2007 | 0.83x | CN¥114.05 Million | CN¥137.30 Million | CN¥23.25 Million | ▲ +36.9% |
| 2006 | 0.61x | CN¥34.13 Million | CN¥56.24 Million | CN¥22.12 Million | ▼ -2.3% |
| 2005 | 0.62x | CN¥100.37 Million | CN¥161.64 Million | CN¥61.27 Million | ▲ +156.2% |
| 2004 | -1.10x | CN¥-69.86 Million | CN¥63.24 Million | CN¥133.10 Million | ▼ -1463.2% |
| 2003 | -0.07x | CN¥-11.83 Million | CN¥167.42 Million | CN¥179.25 Million | ▼ -119.3% |
| 2002 | 0.37x | CN¥115.64 Million | CN¥315.59 Million | CN¥199.94 Million | ▲ +48.1% |
| 2001 | 0.25x | CN¥66.93 Million | CN¥270.43 Million | CN¥203.50 Million | ▲ +102.4% |
| 2000 | -10.21x | CN¥-228.28 Million | CN¥22.36 Million | CN¥250.64 Million | ▼ -493.4% |
| 1999 | -1.72x | CN¥-60.44 Million | CN¥35.12 Million | CN¥95.56 Million | ▲ +28.3% |
| 1998 | -2.40x | CN¥-110.79 Million | CN¥46.18 Million | CN¥156.96 Million | — |